lifestyle.ideacrossing.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NICOX SA
Nicox Provides Full Year 2025 Financial Results and Corporate Update
April 30, 2026
Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting
February 24, 2026
Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
February 16, 2026
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
February 12, 2026
Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques
January 20, 2026